Audentes Therapeutics: 2Q Earnings Snapshot
SAN FRANCISCO (AP) _ Audentes Therapeutics Inc. (BOLD) on Tuesday reported a loss of $31.4 million in its second quarter.
The San Francisco-based company said it had a loss of 85 cents per share.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 78 cents per share.
Audentes Therapeutics shares have increased 22 percent since the beginning of the year. The stock has increased 90 percent in the last 12 months.